Robustness properties of a sequential test for vaccine safety in the presence of misspecification

Statistical Analysis and Data Mining

Volumn 7, Issue 5, 2014, Pages 368-375

  Franks, Riley ^a   Sandhu, Sukhminder ^b   Avagyan, Armen ^a   Lu, Yun ^b   Hong, Han ^a,c   Garcia, Bruno ^a   Worrall, Christopher ^d   Kelman, Jeffrey ^d   Ball, Robert ^b   Macurdy, Thomas ^a,c  

^a Picobella LLC   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

Active surveillance; Administrative data; Claims delay; Pharmacovigilance; Sequential surveillance; Uncertainty; Vaccine safety

Indexed keywords

MONITORING; VACCINES;

ACTIVE SURVEILLANCE; ADMINISTRATIVE DATA; CLAIM DELAY; DELAY DISTRIBUTIONS; MISSPECIFICATION; PHARMACOVIGILANCE; SEQUENTIAL PROBABILITY RATIO TEST; SEQUENTIAL SURVEILLANCE; UNCERTAINTY; VACCINE SAFETY;

PROBABILITY DISTRIBUTIONS;

EID: 84923312533     PISSN: 19321864     EISSN: 19321872     Source Type: Journal    
DOI: 10.1002/sam.11234     Document Type: Article

References (12)

1. L. B. Schonberger, D. J. Bregman, J. Z. Sullivan-Bolyai, R. A. Keenlyside, D. W. Ziegler, H. F. Retailliau, D. L. Eddins, and J. A. Bryan, Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States, 1976-1977, Am J Epidemiol 110(2) (1979), 105-123.
2. A. D. Langmuir, D. J. Bregman, L. T. Kurland, N. Nathanson, and M. Victor, An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines, Am J Epidemiol 119(6) (1984), 841-879.
3. A. G. Hartzema, J. A. Racoosin, T. E. MaCurdy, J. M. Gibbs, and J. A. Kelman, Utilizing medicare claims data for real-time drug safety evaluations: is it feasible?, Pharmacoepidemiol Drug Saf 20(7) (2011), 684-688.
4. D. R. Burwen, S. K. Sandhu, T. E. MaCurdy, J. A. Kelman, J. M. Gibbs, B. Garcia, M. Markatou, R. A. Forshee, H. S. Izurieta, and R. Ball, Surveillance for Guillain-Barré syndrome after influenza vaccination among the medicare population, 2009-2010, Am J Public Health 102(10) (2012), 1921-1927.
5. J. C. Nelson, A. J. Cook, O. Yu, C. Dominguez, S. Zhao, S. K. Greene, B. H. Fireman, S. J. Jacobsen, E. S. Weintraub, and L. A. Jackson, Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data, Pharmacoepidemiol Drug Saf 21 (2012), 62-71.
6. J. C. Maro and J. S. Brown, Impact of exposure accrual on sequential postmarket evaluations: a simulation study, Pharmacoepidemiol Drug Saf 20(11) (2011), 1184-1191.
7. T. R. Avery, M. Kulldorff, Y. Vilk, L. Li, T. Craig Cheetham, S. Dublin, R. L. Davis, L. Liu, L. Herrinton, and J. S. Brown, Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual, Pharmacoepidemiol Drug Saf 22(5) (2013), 488-495.
8. T. MaCurdy, Updating sequential probability ratio test for real-time surveillance of vaccine/drug safety, In Statistical Issues and Challenges in Post-Licensure Safety Surveillance and Treatment Effect Assessment, ASA Biopharmaceutical Section FDA-Industry Statistics Workshop, 2012.
9. A. J. Cook, R. C. Tiwari, R. D. Wellman, S. R. Heckbert, L. Li, P. Heagerty, T. Marsh, and J. C. Nelson, Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the mini-sentinel pilot, Pharmacoepidemiol Drug Saf 21 (2012), 72-81.
10. W. K. Yih, M. Kulldorff, B. H. Fireman, I. M. Shui, E. M. Lewis, N. P. Klein, J. Baggs, E. S. Weintraub, E. A. Belongia, A. Naleway, et al., Active surveillance for adverse events: the experience of the vaccine safety datalink project, Pediatrics 127(suppl 1) (2011), S54-S64.
11. D. A. Salmon, A. Akhtar, M. J. Mergler, K. S. Vannice, H. Izurieta, R. Ball, G. M. Lee, C. Vellozzi, P. Garman, F. Cunningham, et al., Immunization-safety monitoring systems for the 2009 h1n1 monovalent influenza vaccination program, Pediatrics 127(suppl 1) (2011), S78-S86.
12. M. Nguyen, R. Ball, K. Midthun, and T. A. Lieu, The food and drug administration's post-licensure rapid immunization safety monitoring program: strengthening the federal vaccine safety enterprise, Pharmacoepidemiol Drug Saf 21 (2012), 291-297.